Drcom Content Editor, Author at Kybora

Homepage
About Us
Services
News Feed
Contact
English
- English
- 中文

Homepage
About Us
Services
News Feed
Contact
English
- English
- 中文

KYBORA Successfully Helps STADA License Xlucane to Bausch Health

February 26, 2020

Comments are off for this post.

News

KYBORA Successfully Helps STADA License Xlucane to Bausch Health

Recent blog post.

KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market

Posted: 3 weeks ago
Podcast: Healthcare Insights by KYBORA

Posted: 1 month ago
Managing Director – Biopharma Investment Banking (Broker-Dealer Head)

Posted: 1 month ago
KYBORA at BioArbor Life Science Forum

Posted: 1 month ago
Podcast: Healthcare Insights by KYBORA

Posted: 2 months ago

Tags.

#biopharma Licensing AI Announcement Bausch Health biopharma biotechnology China Conference Corporate globalhealthcare healthtech Kybora Team LIcensing March 2020 mergersandacquisitions News Priority List Stada license

Tell us about your business and corporate development needs.

KYBORA is a global advisory firm whose mission is to guide transformative healthcare companies to enduring success globally, by offering optimal M&A, licensing, fundraising and strategic advisory services in all key markets around the world.

About Us.

About KYBORA
Meet our team
Success Story
Our Global Presence

Our Services.

M&A
Licensing
Fundraising
Strategic Advisory

Latest News Feed.

KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market

Posted: 3 weeks ago
Podcast: Healthcare Insights by KYBORA

Posted: 1 month ago

© KYBORA All Rights Reserved.

Terms of service | Privacy policy

TYPE & ENTER: